During the past decade, Hongjian Wang conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hongjian Wang" are "Coronary Artery Disease" (2 trials), "In-stent Restenosis" (1 trials) and "ST Elevation Myocardial Infarction" (1 trials). Many other conditions were trialed in "Hongjian Wang" in a lesser frequency.

Most popular intervention types in "Hongjian Wang" are "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Observation" (1 trials), "Quality improvement strategies and tools" (1 trials) and "Wearable electrocardiogram" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hongjian Wang" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hongjian Wang". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hongjian Wang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hongjian Wang, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".